Ovid Therapeutics Inc.
OVID
$2.70
-$0.05-1.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -220.41% | -65.98% | 204.43% | 13.19% | -154.98% |
| Total Depreciation and Amortization | -83.84% | -75.18% | -89.38% | -90.53% | -33.11% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2.09% | -35.36% | -32,516.13% | 67.13% | 103.89% |
| Change in Net Operating Assets | -192.20% | 278.97% | 115.71% | 3.09% | -129.70% |
| Cash from Operations | -268.54% | -35.20% | -4.00% | 14.23% | 66.51% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -819.65% | 16.62% | -438.10% | 1,654.51% | -6.25% |
| Cash from Investing | -819.65% | 16.62% | -438.45% | 1,630.48% | -6.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | 666,176.92% | -- | -60.53% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | 684,376.92% | -- | -60.53% | -100.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1,236.65% | 1,666.52% | -166.09% | 46.83% | 775.23% |